Dados B3 › Watcher
Watcher for PCAR3: events of COMPANHIA BRASILEIRA DE DISTRIBUIÇÃO
24 event(s) recorded for PCAR3, newest first. Each is a fact with both numbers and the filing that revealed it.
Type: all · Profit or loss · Net margin changed band · Net debt/EBITDA changed band · Restated financial statements · Confidence flag changed colour
| Public on | Type | Fact |
|---|---|---|
| 2026-05-14 | Profit or loss | Profit turned into loss in 1Q2026: net margin from 3.0% in 3Q2025 to -32.8% in 1Q2026.ITR 1T2026, recebida pela CVM em 14/05/2026 |
| 2026-02-24 | Net debt/EBITDA changed band | Net debt/EBITDA went from 1.9x in 2024 to 2.1x in 2025.DFP 2025, recebida pela CVM em 24/02/2026 |
| 2025-11-04 | Profit or loss | Loss turned into profit in 3Q2025: net margin from -4.6% in 2Q2025 to 3.0% in 3Q2025.ITR 3T2025, recebida pela CVM em 04/11/2025 |
| 2025-02-18 | Restated financial statements | 2023 statements restated in the 2024 annual filing: 3 accounts changed by 5% or more; the largest, profit from continuing operations (DRE 3.09), went from R$ 86.0 m to R$ 72.0 m.DFP 2024, recebida pela CVM em 18/02/2025, contra a DFP 2023 |
| 2023-02-27 | Restated financial statements | 2021 statements restated in the 2022 annual filing: 7 accounts changed by 5% or more; the largest, profit before taxes (DRE 3.07), went from R$ 369.0 m to R$ -570.0 m.DFP 2022, recebida pela CVM em 27/02/2023, contra a DFP 2021 |
| 2023-02-27 | Profit or loss | Profit turned into loss in 2022: net margin from 1.9% in 2021 to -0.0% in 2022.DFP 2022, recebida pela CVM em 27/02/2023 |
| 2022-07-27 | Profit or loss | Profit turned into loss in 2Q2022: net margin from 14.2% in 1Q2022 to -1.2% in 2Q2022.ITR 2T2022, recebida pela CVM em 27/07/2022 |
| 2022-05-04 | Profit or loss | Loss turned into profit in 1Q2022: net margin from -0.3% in 3Q2021 to 14.2% in 1Q2022.ITR 1T2022, recebida pela CVM em 04/05/2022 |
| 2021-11-03 | Profit or loss | Profit turned into loss in 3Q2021: net margin from 0.2% in 2Q2021 to -0.3% in 3Q2021.ITR 3T2021, recebida pela CVM em 03/11/2021 |
| 2021-02-23 | Restated financial statements | 2019 statements restated in the 2020 annual filing: 7 accounts changed by 5% or more; the largest, profit from continuing operations (DRE 3.09), went from R$ 488.0 m to R$ -273.0 m.DFP 2020, recebida pela CVM em 23/02/2021, contra a DFP 2019 |
| 2020-10-28 | Restated financial statements | 2018 statements restated in the 2019 annual filing: 16 accounts changed by 5% or more; the largest, internal changes in equity (DMPL 5.06), went from R$ -5.0 m to R$ -9.0 m.DFP 2019, recebida pela CVM em 28/10/2020, contra a DFP 2018 |
| 2020-07-29 | Profit or loss | Loss turned into profit in 2Q2020: net margin from -0.6% in 1Q2020 to 1.8% in 2Q2020.ITR 2T2020, recebida pela CVM em 29/07/2020 |
| 2020-05-14 | Profit or loss | Profit turned into loss in 1Q2020: net margin from 1.2% in 3Q2019 to -0.6% in 1Q2020.ITR 1T2020, recebida pela CVM em 14/05/2020 |
| 2019-03-26 | Restated financial statements | 2017 statements restated in the 2018 annual filing: 5 accounts changed by 5% or more; the largest, net income plus OCI (DMPL 5.05), went from R$ 847.0 m to R$ 776.0 m.DFP 2018, recebida pela CVM em 26/03/2019, contra a DFP 2017 |
| 2018-02-19 | Profit or loss | Loss turned into profit in 2017: net margin from -2.6% in 2016 to 1.9% in 2017.DFP 2017, recebida pela CVM em 19/02/2018 |
| 2017-05-05 | Profit or loss | Loss turned into profit in 1Q2017: net margin from -2.0% in 3Q2016 to 2.0% in 1Q2017.ITR 1T2017, recebida pela CVM em 05/05/2017 |
| 2017-03-07 | Restated financial statements | 2015 statements restated in the 2016 annual filing: 7 accounts changed by 5% or more; the largest, profit from continuing operations (DRE 3.09), went from R$ -276.0 m to R$ 615.0 m.DFP 2016, recebida pela CVM em 07/03/2017, contra a DFP 2015 |
| 2017-03-07 | Net debt/EBITDA changed band | Net debt/EBITDA went from -1.1x in 2015 to 0.4x in 2016.DFP 2016, recebida pela CVM em 07/03/2017 |
| 2016-10-28 | Profit or loss | Profit turned into loss in 2Q2015: net margin from 1.5% in 1Q2015 to -0.1% in 2Q2015.ITR 2T2015, recebida pela CVM em 28/10/2016 |
| 2016-07-29 | Restated financial statements | 2014 statements restated in the 2015 annual filing: 5 accounts changed by 5% or more; the largest, profit in the statement of changes in equity (DMPL 5.05.01), went from R$ 1.76 bn to R$ 1.58 bn.DFP 2015, recebida pela CVM em 29/07/2016, contra a DFP 2014 |
| 2016-07-29 | Profit or loss | Profit turned into loss in 2015: net margin from 2.7% in 2014 to -0.4% in 2015.DFP 2015, recebida pela CVM em 29/07/2016 |
| 2015-02-12 | Net debt/EBITDA changed band | Net debt/EBITDA went from 0.3x in 2013 to -0.3x in 2014.DFP 2014, recebida pela CVM em 12/02/2015 |
| 2013-02-20 | Net debt/EBITDA changed band | Net debt/EBITDA went from 2.2x in 2011 to 0.9x in 2012.DFP 2012, recebida pela CVM em 20/02/2013 |
| 2012-02-16 | Restated financial statements | 2010 statements restated in the 2011 annual filing: 9 accounts changed by 5% or more; the largest, transactions with shareholders (DMPL 5.04), went from R$ 67.1 m to R$ -104.5 m.DFP 2011, recebida pela CVM em 16/02/2012, contra a DFP 2010 |
PCAR3 — company page · all events · JSON · how the watcher works. Descriptive, not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 10:02 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 10:02 UTC. If this does not match /saude, you are reading a cached copy.